Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02990793 · ClinicalTrials.gov registry record · NA
Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder
A NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury, sponsored by Wave Neuroscience.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
- 8
- Study locations
NCT02990793: Completed NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury, sponsored by Wave Neuroscience.
NCT02990793 is a NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury that has completed, run by Wave Neuroscience. The registered enrollment target is 158 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (76% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02990793, a NA study of Post Traumatic Stress Disorder and Traumatic Brain Injury, has completed, sponsored by Wave Neuroscience.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder
Primary Outcome
Change in PTSD symptoms as measured by the PTSD Checklist-5 (PCL-5).
Conditions Studied
Interventions
- DEVICE Active MeRT Treatment
- DEVICE Sham MeRT Treatment
Study Locations (8)
California
- BrainHealth Solutions - Costa Mesa
- VA Long Beach Healthcare System - Long Beach
- SoCal Neuroscience Research Unit - San Diego
North Carolina
- UNC Rex Hospital - Raleigh
Ohio
- Columbus Brain Research Center - Columbus
Pennsylvania
- Center for Interventional Pain and Spine - Bryn Mawr
Texas
- Texas A&M Research Center - Plano
Washington
- Seattle Neuropsychiatric Treatment Center (Seattle NTC) - Bellevue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2025-11-04 |
| Phase | NA |
What the finished NCT02990793 record still lists
NCT02990793 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (76% lower).
The record links to 3 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Active MeRT Treatment is the first listed.
NCT02990793 lists 8 locations in 6 states (California, North Carolina, Ohio).
Frequently Asked Questions
What is clinical trial NCT02990793 about?
NCT02990793 is a clinical study titled "Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder". The purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder
What is the current status of trial NCT02990793?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2022-04-04. Estimated completion is 2025-11-04.
What conditions does trial NCT02990793 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Traumatic Brain Injury, Postconcussive Symptoms.
What interventions are being tested in trial NCT02990793?
The interventions under investigation include: Active MeRT Treatment (DEVICE), Sham MeRT Treatment (DEVICE).
Who is sponsoring clinical trial NCT02990793?
This trial is sponsored by Wave Neuroscience, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02990793 being conducted?
This trial has 8 study locations across California, North Carolina, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02990793's enrollment target sits among peer trials
158 76th of 262 higher than 187 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI